an experimental cancer drug axed over poor results may have the ability to reverse the effects of alzheimer 's , experts have revealed
scientists at yale university in connecticut in the us have revealed how the treatment , called azdo5030 , restored memory in mice given alzheimer 's disease
an experimental cancer drug axed over poor results may have the ability to reverse the effects of alzheimer 's , experts have revealed ( file picture ) the drug worked by blocking a process that breaks nerve connections in the brain used to store memory
researchers say the study has led to the launch of human trials to test the efficacy of the drug in alzheimer 's patients
mr strittmatter and his co-author christopher van dyck have already started a ' multi-site clinical trial ' to determine whether the drug can also benefit alzheimer 's patients